Literature DB >> 29086221

Expression of PYCARD gene transcript variant mRNA in peripheral blood mononuclear cells of primary gout patients with different Chinese medicine syndromes.

Wan-Tai Dang1,2, Wen-Guang Xie2, Jing-Guo Zhou3.   

Abstract

OBJECTIVE: To study the expression level and role of apoptosis-associated speck-like protein containing a caspase recruitment domain (PYCARD) gene transcript variant mRNA in peripheral blood mononuclear cells (PBMCs) of primary gout (PG) patients with different Chinese medicine (CM) syndromes.
METHODS: The expressions of PYCARD gene transcript variant mRNA and interleukin-1β (IL-1β) mRNA in PBMCs were investigated in 96 PG patients with acute phase (APPG, 44 cases) and non-acute phase (NAPPG, 52 cases) and 30 healthy controls (HCs) by reverse transcription-polymerase chain reaction (PCR) and/or realtime quantitative PCR. PYCARD and nuclear factor-κB (p50) [NF-κB (p50)] protein was detected by Western blot in PBMCs respectively. IL-1β, IL-4 and IL-10 protein levels in plasma of HCs and PG patients were measured by enzyme-linked immuno sorbent assay.
RESULTS: The main CM syndromes in APPG patients were obstruction of dampness and heat syndrome (ODHS, 36.36%) and intermingled phlegm-blood stasis syndrome (IPBSS, 27.27%), while in NAPPG patients were Pi (Spleen)-deficiency induced dampness syndrome (PDIDS, 40.38%) and qi-blood deficiency syndrome (QBDS, 26.92%). It showed statistical significances of the expressions of PYCARD gene and its transcript variant mRNA, the protein of PYCARD and NF-κB (p50) and the plasma IL-1β, IL-4 and IL-10 in APPG, NAPPG, ODHS, IPBSS, PDIDS and QBDS groups, compared with the HC group respectively (P<0.05 or P<0.01). There were also significant differences of mRNA expressions of PYCARD-1 and PYCARD-2 as well as protein expressions of IL-1β, IL-4 and IL-10 among the 4 CM syndromes groups (P<0.05 or P<0.01). Correlation analysis showed positive correlation between the mRNA expressions of PYCARD-1 gene transcript variant and IL-1β in APPG patients (r=0.3088, P=0.0183).
CONCLUSION: PYCARD gene and its transcript variant may play a critical and regulative role in the inflflammatory response of PG patients with different phases and CM syndromes.

Entities:  

Keywords:  Chinese medicine syndrome; PYCARD; gene; primary gout; transcript variant

Mesh:

Substances:

Year:  2017        PMID: 29086221     DOI: 10.1007/s11655-017-2826-9

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  24 in total

1.  Deciphering the splicing code.

Authors:  Yoseph Barash; John A Calarco; Weijun Gao; Qun Pan; Xinchen Wang; Ofer Shai; Benjamin J Blencowe; Brendan J Frey
Journal:  Nature       Date:  2010-05-06       Impact factor: 49.962

Review 2.  The role of interleukin-1 and the inflammasome in gout: implications for therapy.

Authors:  Richard M Pope; Jürg Tschopp
Journal:  Arthritis Rheum       Date:  2007-10

3.  Can new diagnostic criteria of rheumatoid arthritis really make an early diagnosis? --A case report of early diagnosis and treatment of early rheumatoid arthritis with Chinese medicine.

Authors:  Yan-jun Kong; Qian-de Zhang; Mu-xin Wei
Journal:  Chin J Integr Med       Date:  2015-05-06       Impact factor: 1.978

4.  Prion-like polymerization underlies signal transduction in antiviral immune defense and inflammasome activation.

Authors:  Xin Cai; Jueqi Chen; Hui Xu; Siqi Liu; Qiu-Xing Jiang; Randal Halfmann; Zhijian J Chen
Journal:  Cell       Date:  2014-03-13       Impact factor: 41.582

5.  [Comparative analysis of clinical indicators of gout patients of different syndrome types and its significance].

Authors:  Wan-Tai Dang; Jing-Guo Zhou; Wen-Guang Xie; Yu-Feng Qing; Shu-Yue Pan; Meng-Yun Zhang; Meng-Jun Pu
Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi       Date:  2013-10

6.  Population-Specific Resequencing Associates the ATP-Binding Cassette Subfamily C Member 4 Gene With Gout in New Zealand Māori and Pacific Men.

Authors:  Callum Tanner; James Boocock; Eli A Stahl; Amanda Dobbyn; Asim K Mandal; Murray Cadzow; Amanda J Phipps-Green; Ruth K Topless; Jennie Harré Hindmarsh; Lisa K Stamp; Nicola Dalbeth; Hyon K Choi; David B Mount; Tony R Merriman
Journal:  Arthritis Rheumatol       Date:  2017-05-31       Impact factor: 10.995

7.  Gout-associated uric acid crystals activate the NALP3 inflammasome.

Authors:  Fabio Martinon; Virginie Pétrilli; Annick Mayor; Aubry Tardivel; Jürg Tschopp
Journal:  Nature       Date:  2006-01-11       Impact factor: 49.962

8.  The PYRIN-CARD protein ASC is an activating adaptor for caspase-1.

Authors:  Srinivasa M Srinivasula; Jean-Luc Poyet; Marjaneh Razmara; Pinaki Datta; ZhiJia Zhang; Emad S Alnemri
Journal:  J Biol Chem       Date:  2002-04-19       Impact factor: 5.157

9.  Apoptosis-associated speck-like protein containing a caspase recruitment domain is a regulator of procaspase-1 activation.

Authors:  Christian Stehlik; Sug Hyung Lee; Andrea Dorfleutner; Angela Stassinopoulos; Junji Sagara; John C Reed
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

10.  Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China.

Authors:  Zhimin Miao; Changgui Li; Ying Chen; Shihua Zhao; Yangang Wang; Zhongchao Wang; Xinyan Chen; Feng Xu; Fang Wang; Ruixia Sun; Jianxia Hu; Wei Song; Shengli Yan; Cong-Yi Wang
Journal:  J Rheumatol       Date:  2008-07-15       Impact factor: 4.666

View more
  3 in total

1.  PD-1 mRNA expression in peripheral blood mononuclear cells as a biomarker for different stages of primary gouty arthritis.

Authors:  Jing Su; Xuefang Zhang; Qing Zhao; Zhaodi Guo; Jianxiong Wu; Guoqiang Chen; Qianxin Liang; Zhixiang Chen; Zhiliang He; Xiuping Cai; Manlin Xie; Lei Zheng; Kewei Zhao
Journal:  J Cell Mol Med       Date:  2020-07-08       Impact factor: 5.310

2.  The efficacy and tolerability of febuxostat treatment in a cohort of Chinese Han population with history of gout.

Authors:  Yuan-Yuan Huang; Zhuang Ye; San-Wei Gu; Zhen-Yu Jiang; Ling Zhao
Journal:  J Int Med Res       Date:  2020-05       Impact factor: 1.671

3.  Oral Huzhang granules for the treatment of acute gouty arthritis: protocol for a double-blind, randomized, controlled trial.

Authors:  Mi Zhou; Liang Hua; Yi-Fei Wang; Si-Ting Chen; Chun-Mei Yang; Ming Zhang; Xin Li; Bin Li
Journal:  Trials       Date:  2022-04-01       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.